Financial statements Biofaktor
Balance sheet data of BIOFAKTOR
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 50 628 517,22 | 51 050 981,97 | 56 896 277,00 | 57 458 268,42 | 61 630 770,38 | 58 981 350,11 |
| A. Fixed assets | 38 503 660,29 | 40 029 937,35 | 42 729 613,68 | 41 755 958,11 | 43 157 814,87 | 42 600 119,19 |
| B. Current assets | 12 124 856,93 | 11 021 044,62 | 14 166 663,32 | 15 702 310,31 | 18 472 955,51 | 16 381 230,92 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 50 628 517,22 | 51 050 981,97 | 56 896 277,00 | 57 458 268,42 | 61 630 770,38 | 58 981 350,11 |
| A. Equity | 29 355 669,24 | 30 737 924,57 | 32 099 396,71 | 33 517 132,94 | 33 092 529,27 | 32 950 489,21 |
| B. Liabilities and provisions for liabilities | 21 272 847,98 | 20 313 057,40 | 24 796 880,29 | 23 941 135,48 | 28 538 241,11 | 26 030 860,90 |
| I. Long-term liabilities | 207 722,70 | 8 969 000,00 | 12 213 175,88 | 12 560 175,88 | 7 604 526,47 | 5 048 700,99 |
| II. Short-term liabilities | 20 514 656,24 | 10 835 387,41 | 12 075 034,42 | 10 872 289,61 | 20 248 398,03 | 20 350 871,92 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.